All Stories

  1. Identification of a Pathogenic PSEN1 Ala285Val Mutation Associated with Early-Onset Alzheimer’s Disease
  2. Novel prion mutation (p.Tyr225Cys) in a Korean patient with atypical Creutzfeldt–Jakob disease
  3. Early-onset Alzheimer’s disease patient with prion (PRNP) p.Val180Ile mutation
  4. Recent advances in the treatment of C. difficile using biotherapeutic agents
  5. Recent advances in the treatment of pathogenic infections using antibiotics and nano-drug delivery vehicles
  6. Identification of a novel mutation in APP gene in a Thai subject with early-onset Alzheimer's disease
  7. Characterization of mutations in PRNP (prion) gene and their possible roles in neurodegenerative diseases
  8. A pathogenic PSEN2 p.His169Asn mutation associated with early-onset Alzheimer’s disease
  9. Genome-editing applications of CRISPR–Cas9 to promote in vitro studies of Alzheimer’s disease
  10. Apolipoprotein ε7 allele in memory complaints: insights through protein structure prediction
  11. 11C-PIB PET imaging reveals that amyloid deposition in cases with early-onset Alzheimer’s disease in the absence of known mutations retains higher levels of PIB in the basal ganglia
  12. A case of possibly pathogenic PSEN2 R62C mutation in a patient with probable early-onset Alzheimer’s dementia supported by structure prediction
  13. A genetic screen of the mutations in the Korean patients with early-onset Alzheimer’s disease
  14. Monitoring the effects of doxorubicin on 3D-spheroid tumor cells in real-time
  15. PSEN1 L226F mutation in a patient with early-onset Alzheimer’s disease in Korea
  16. Diminazene aceturate: an antibacterial agent for Shiga-toxin-producing Escherichia coli O157:H7
  17. Mutations, associated with early-onset Alzheimer’s disease, discovered in Asian countries
  18. Real-time monitoring of cisplatin cytotoxicity on three-dimensional spheroid tumor cells
  19. Causative factors for formation of toxic islet amyloid polypeptide oligomer in type 2 diabetes mellitus
  20. Improvement in the amine glass platform by bubbling method for a DNA microarray
  21. Biocompatible and biodegradable fibrinogen microspheres for tumor-targeted doxorubicin delivery
  22. Investigation of the biological and anti-cancer properties of ellagic acid-encapsulated nano-sized metalla-cages
  23. Identification of two novel mutations, PSEN1 E280K and PRNP G127S, in a Malaysian family
  24. Magnetic microparticle-based multimer detection system for the detection of prion oligomers in sheep
  25. Comparative hyperthermia effects of silica–gold nanoshells with different surface coverage of gold clusters on epithelial tumor cells
  26. Targeting cancer stem cells by using the nanoparticles
  27. Measurement of creatinine in human plasma using a functional porous polymer structure sensing motif
  28. Spotlight on nano-theranostics in South Korea: applications in diagnostics and treatment of diseases
  29. Spherulitic copper–copper oxide nanostructure-based highly sensitive nonenzymatic glucose sensor
  30. A regenerative label-free fiber optic sensor using surface plasmon resonance for clinical diagnosis of fibrinogen
  31. Ultraviolet light and laser irradiation
  32. E coli detection
  33. A beggar wears heaven as a blanket
  34. Core-shell nanostructured hybrid composites for volatile organic compound detection
  35. Lipid-coated gold nanocomposites for enhanced cancer therapy
  36. Optical birefringence of liquid crystals for label-free optical biosensing diagnosis
  37. Ultraviolet light and laser irradiation enhances the antibacterial activity of glucosamine-functionalized gold nanoparticles
  38. Bone dynamics in the upward direction after a maxillary sinus floor elevation procedure: serial segmentation using synchrotron radiation micro-computed tomography
  39. Selective detection of dopamine in the presence of ascorbic acid via fluorescence quenching of InP/ZnS quantum dots
  40. Today’s diverse nano-theranostic applications and tomorrow’s promises
  41. Anticancer activities of self-assembled molecular bowls containing a phenanthrene-based donor and Ru(II) acceptors
  42. Ultrafast sonochemical synthesis of protein-inorganic nanoflowers
  43. Current applications of graphene oxide in nanomedicine
  44. Amperometric urea biosensors based on sulfonated graphene/polyaniline nanocomposite
  45. The characteristic AgcoreAushell nanoparticles as SERS substrates in detecting dopamine molecules at various pH ranges
  46. Graphene oxide-modified ZnO particles: synthesis, characterization, and antibacterial properties
  47. Dopamine-functionalized InP/ZnS quantum dots as fluorescence probes for the detection of adenosine in microfluidic chip
  48. Mutations in presenilin 2 and its implications in Alzheimer’s disease and other dementia-associated disorders
  49. Role of apolipoprotein E in neurodegenerative diseases
  50. Analyses of protein corona on bare and silica-coated gold nanorods against four mammalian cells
  51. Oxidative stress and antibacterial properties of a graphene oxide-cystamine nanohybrid
  52. Safety assessment of silica and zinc oxide nanoparticles
  53. Organization of research team for nano-associated safety assessment in effort to study nanotoxicology of zinc oxide and silica nanoparticles
  54. Current investigations into the genotoxicity of zinc oxide and silica nanoparticles in mammalian models in vitro and in vivo: carcinogenic/genotoxic potential, relevant mechanisms and biomarkers, artifacts, and limitations
  55. Interactive survey of consumer awareness of nanotechnologies and nanoparticles in consumer products in South Korea
  56. Biokinetics of zinc oxide nanoparticles: toxicokinetics, biological fates, and protein interaction
  57. Comparative analysis of nanotechnology awareness in consumers and experts in South Korea
  58. Surface treatment of silica nanoparticles for stable and charge-controlled colloidal silica
  59. Physicochemical properties of surface charge-modified ZnO nanoparticles with different particle sizes
  60. Effects of surface-modifying ligands on the colloidal stability of ZnO nanoparticle dispersions in in vitro cytotoxicity test media
  61. Toxicity of colloidal silica nanoparticles administered orally for 90 days in rats
  62. A 90-day study of subchronic oral toxicity of 20 nm, negatively charged zinc oxide nanoparticles in Sprague Dawley rats
  63. Toxicity of 100 nm zinc oxide nanoparticles: a report of 90-day repeated oral administration in Sprague Dawley rats
  64. Evaluation of silica nanoparticle toxicity after topical exposure for 90 days
  65. Zinc oxide nanoparticles: a 90-day repeated-dose dermal toxicity study in rats
  66. Effect of zinc oxide nanoparticles on dams and embryo–fetal development in rats
  67. Prenatal development toxicity study of zinc oxide nanoparticles in rats
  68. Undetactable levels of genotoxicity of SiO2 nanoparticles in in vitro and in vivo tests
  69. Immunotoxicity of silicon dioxide nanoparticles with different sizes and electrostatic charge
  70. Immunotoxicity of zinc oxide nanoparticles with different size and electrostatic charge
  71. In vitro cytotoxicity of SiO2 or ZnO nanoparticles with different sizes and surface charges on U373MG human glioblastoma cells
  72. Optical imaging of absorption and distribution of RITC-SiO2 nanoparticles after oral administration
  73. Tissue distribution and excretion kinetics of orally administered silica nanoparticles in rats
  74. Analysis of SiO2 nanoparticles binding proteins in rat blood and brain homogenate
  75. Analysis of zinc oxide nanoparticles binding proteins in rat blood and brain homogenate
  76. Assessment of ZnO and SiO2 nanoparticle permeability through and toxicity to the blood–brain barrier using Evans blue and TEM
  77. A 90-day study of sub-chronic oral toxicity of 20 nm positively charged zinc oxide nanoparticles in Sprague Dawley rats
  78. Role of surface modification in zinc oxide nanoparticles and its toxicity assessment toward human dermal fibroblast cells
  79. The genetics of Alzheimer's disease
  80. Fibrinogen and fibrin based micro and nano scaffolds incorporated with drugs, proteins, cells and genes for therapeutic biomedical applications
  81. Improved fibronectin-immobilized fibrinogen microthreads for the attachment and proliferation of fibroblasts